JP2019524732A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524732A5
JP2019524732A5 JP2019501630A JP2019501630A JP2019524732A5 JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5 JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5
Authority
JP
Japan
Prior art keywords
methyl
thiazol
methoxy
methylquinoxalin
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524732A (ja
JP6903732B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041880 external-priority patent/WO2018013776A1/en
Publication of JP2019524732A publication Critical patent/JP2019524732A/ja
Publication of JP2019524732A5 publication Critical patent/JP2019524732A5/ja
Application granted granted Critical
Publication of JP6903732B2 publication Critical patent/JP6903732B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501630A 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物 Active JP6903732B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362121P 2016-07-14 2016-07-14
US62/362,121 2016-07-14
PCT/US2017/041880 WO2018013776A1 (en) 2016-07-14 2017-07-13 Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors

Publications (3)

Publication Number Publication Date
JP2019524732A JP2019524732A (ja) 2019-09-05
JP2019524732A5 true JP2019524732A5 (enExample) 2020-08-06
JP6903732B2 JP6903732B2 (ja) 2021-07-14

Family

ID=59384259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501630A Active JP6903732B2 (ja) 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物

Country Status (7)

Country Link
US (2) US20190315774A1 (enExample)
EP (1) EP3484894B1 (enExample)
JP (1) JP6903732B2 (enExample)
KR (1) KR102468661B1 (enExample)
CN (1) CN109689664B (enExample)
ES (1) ES2823127T3 (enExample)
WO (1) WO2018013776A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102460385B1 (ko) 2016-07-14 2022-10-27 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
CN109689642B (zh) 2016-07-14 2022-04-12 百时美施贵宝公司 经单环杂芳基取代的化合物
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
CN117285527A (zh) * 2023-09-25 2023-12-26 中国药科大学 一种噌啉类par4拮抗剂及其医药应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
TW279162B (enExample) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6387942B2 (en) * 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
TW200517381A (en) 2003-08-01 2005-06-01 Genelabs Tech Inc Bicyclic heteroaryl derivatives
WO2005113522A1 (en) 2004-05-07 2005-12-01 Janssen Pharmaceutica, N.V. Azole carboxamide inhibitors of bacterial type iii protein secretion systems
US20090054417A1 (en) 2004-07-28 2009-02-26 Irm Llc Compounds and compositions as modulators of steroid hormone nuclear receptors
RU2007130896A (ru) 2005-01-14 2009-02-20 Дженелэбс Текнолоджиз, Инк. (Us) Индольные производные для лечения вирусных инфекций
US20080015193A1 (en) 2006-06-20 2008-01-17 Mendoza Jose S Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
KR101237623B1 (ko) 2006-06-29 2013-02-26 에프. 호프만-라 로슈 아게 벤즈이미다졸 유도체, 이의 제조방법, fxr 작용물질로서이의 용도, 및 이를 함유하는 약학 제제
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
EA201000915A1 (ru) 2007-11-30 2011-02-28 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Ингибиторы пролилгидроксилазы
ES2586459T3 (es) 2008-05-01 2016-10-14 Glaxosmithkline Llc Quinolinas y análogos relacionados como moduladores de sirtuina
GEP20125502B (en) 2008-05-23 2012-04-25 Novartis Ag Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
AU2009274023A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
WO2013130660A1 (en) 2012-02-28 2013-09-06 Amgen Inc. Amides as pim inhibitors
ES2617879T3 (es) * 2012-04-26 2017-06-20 Bristol-Myers Squibb Company Derivados de imidazotiadiazol e imidazopiridazina como inhibidores del receptor activado por proteasa 4 (PAR4) para el tratamiento de la agregación plaquetaria
DK3632919T3 (da) 2012-04-26 2022-11-14 Bristol Myers Squibb Co Farmaceutiske sammensætninger omfattende imidazothiadiazol- og imidazopyrazinderivater som proteaseaktiverede receptor 4-(par4)- hæmmere til behandling af blodpladeaggregering
CA2871637A1 (en) 2012-04-26 2013-10-31 Bristol-Myers Squibb Company Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
CA2922542A1 (en) * 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US10238638B2 (en) 2015-02-26 2019-03-26 Universite De Montreal Benzothiazole and benzothiophene compounds
WO2016134450A1 (en) 2015-02-26 2016-09-01 Université de Montréal Imidazopyridazine and imidazothiadiazole compounds
WO2017019828A1 (en) * 2015-07-30 2017-02-02 Bristol-Myers Squibb Company Aryl substituted bicyclic heteroaryl compounds
KR102460385B1 (ko) 2016-07-14 2022-10-27 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
CN109689642B (zh) 2016-07-14 2022-04-12 百时美施贵宝公司 经单环杂芳基取代的化合物

Similar Documents

Publication Publication Date Title
JP2019524732A5 (enExample)
JP2019528247A5 (enExample)
JP4638355B2 (ja) チアゾール誘導体
US8129394B2 (en) Heteroaryl-substituted imidazole compounds and uses thereof
US8865732B2 (en) Heterocyclic compounds and uses thereof
JP2019514878A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
US9181272B2 (en) Aldosterone synthase inhibitors
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2020527560A5 (enExample)
JP2013530199A (ja) キナーゼ阻害剤として有用な環状エーテル化合物
CA3118934A1 (en) Pyridazinone compounds and uses thereof
RU2020124138A (ru) Производные аминопиридина в качестве ингибиторов фосфатидилинозитолфосфаткиназы
RU2017120859A (ru) Замещенные мостиковые аналоги мочевины в качестве модуляторов сиртуина
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
JP2015528022A5 (enExample)
JP2013545744A5 (enExample)
JP2018530591A5 (enExample)
EP2909193A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JP2018524338A5 (enExample)
JP2019521153A5 (enExample)
JP2015521999A5 (enExample)
JP2019505595A5 (enExample)
JP2018508553A5 (enExample)